Stocks
Cardio Diagnostics Holdings, Inc.CDIO
NASDAQHealthcareBiotechnology$1.77
Price as of · delayed, not real-time
A molecular diagnostics company developing epigenetic and genetic tests for cardiovascular disease detection and management. Its flagship product, the Epi+Gen CHD test, uses a blood sample to assess coronary heart disease risk, positioning it in the emerging precision cardiology market. Investors track CDIO for its potential to disrupt traditional cardiac testing through a non-invasive, AI-driven approach.
52W Range: $0.97-$7.91
Congressional Interest in Cardio Diagnostics Holdings, Inc. (CDIO)
No congressional trades have been disclosed for Cardio Diagnostics Holdings, Inc. (CDIO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CDIO?
No congressional trades found for this stock.